This month, the New York State Office of Cannabis Management (OCM) submitted public comment to the federal government.
In addition to extending its support to the Drug Enforcement Administration (DEA) and the Department of Justice (DOJ) in reevaluating marijuana’s status under the Controlled Substances Act (CSA).
“… 88% of Americans who support cannabis legalization …”
This historic step aligns with the views of 88% of Americans who support cannabis legalization and reflects the growing consensus that cannabis should be regulated and accessible for both medical and adult-use purposes.
New York State, with its decade-long state-run medical cannabis program and the 2021 legalization of adult-use cannabis, has been at the forefront of regulating the cannabis industry to protect public health and safety.
The federal rescheduling of marijuana from Schedule I to Schedule III acknowledges its medicinal value, consistent with recent recommendations from the Department of Health and Human Services (HHS).
OCM also requested additional guidance from the federal government, like the Cole Memorandum (2013), which outlined the federal government’s enforcement priorities and commitment to allowing states to regulate cannabis through their state-run programs.
New York’s cannabinoid hemp, adult-use, and medical cannabis programs include hundreds of licensees and over 100,000 medical cannabis patients who depend on access to regulated cannabis.
While rescheduling marijuana to Schedule III is a positive change, state-regulated cannabis programs need assurance from the federal government that these programs will remain stable and accessible to consumers as new federal guidance is developed.
Become a Harlem Insider!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
